Novel contact–kinin inhibitor sylvestin targets thromboinflammation and ameliorates ischemic stroke-Reference-Cited by-同舟云学术

Novel contact–kinin inhibitor sylvestin targets thromboinflammation and ameliorates ischemic stroke

Published:2022-04-13 Issue:5 Volume:79 Page:
ISSN:1420-682X
Container-title:Cellular and Molecular Life Sciences
language:en
Short-container-title:Cell. Mol. Life Sci.

Author:

Zhang Zhiye,Shen Chuanbin,Fang Mingqian,Han Yajun,Long Chengbo,Liu Weihui,Yang Min,Liu Ming,Zhang Dengdeng,Cao Qiqi,Chen Xue,Fang Yaqun,Lu Qiumin,Hou Zongliu,Li Yaxiong,Liu Zhenze,Lei Xi,Ni Heyu,Lai Ren^ORCID

Funder

National Natural Science Foundation of China

Heart and Stroke Foundation of Canada

Publisher

Springer Science and Business Media LLC

Subject

Cell Biology,Cellular and Molecular Neuroscience,Pharmacology,Molecular Biology,Molecular Medicine

Link

https://link.springer.com/content/pdf/10.1007/s00018-022-04257-7.pdf

Reference76 articles.

1. Chamorro A, Dirnagl U, Urra X, Planas AM (2016) Neuroprotection in acute stroke: Targeting excitotoxicity, oxidative and nitrosative stress, and inflammation. Lancet Neurol 15:869–881

2. Xing C, Arai K, Lo EH, Hommel M (2012) Pathophysiologic cascades in ischemic stroke. Int J Stroke 7:378–385

3. Mattson MP, Culmsee C, Yu ZF (2000) Apoptotic and antiapoptotic mechanisms in stroke. Cell Tissue Res 301:173–187

4. Szydlowska K, Tymianski M (2010) Calcium, ischemia and excitotoxicity. Cell Calcium 47:122–129

5. Spagnoli LG, Mauriello A, Sangiorgi G, Fratoni S, Bonanno E, Schwartz RS, Piepgras DG, Pistolese R, Ippoliti A, Holmes DR Jr (2004) Extracranial thrombotically active carotid plaque as a risk factor for ischemic stroke. JAMA 292:1845–1852

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. ShSPI Inhibits Thrombosis Formation and Ischemic Stroke In Vivo;International Journal of Molecular Sciences;2024-08-19

2. The Role of Thrombo-inflammation in Ischemic Stroke: Focus on the Manipulation and Clinical Application;Molecular Neurobiology;2024-08-06

3. Discovery of Highly Selective, Potent, Covalent, and Orally Bioavailable Factor XIIa Inhibitors for the Treatment of Thrombo-Inflammation;Journal of Medicinal Chemistry;2024-06-24

4. A Nonbactericidal Anionic Antimicrobial Peptide Provides Prophylactic and Therapeutic Efficacies against Bacterial Infections in Mice by Immunomodulatory–Antithrombotic Duality;Journal of Medicinal Chemistry;2024-04-30

5. Recent advances in the discovery and development of drugs targeting the kallikrein-kinin system;Journal of Translational Medicine;2024-04-26